Addressing sex-disparities in the timing of diagnosis and pharmacological therapy has the potential to improve the care of females with obstructive hypertrophic cardiomyopathy.
Addressing sex-disparities in the timing of diagnosis and pharmacological therapy has the potential to improve the care of females with oHCM.
Javidgonbadi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: